Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 6/20 | 0.45 |
| ▸ | DRD3 | P35462 | 6/20 | 0.45 |
| ▸ | DRD4 | P21917 | 4/20 | 0.45 |
| ▸ | HTR2A | P28223 | 2/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | PTK2B | Q14289 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16463118 | 0.81 | ADRA2C (0.43) | DRD2DRD3DRD4HTR2ADRD1 | |
| SCHEMBL6200811 | 0.81 | CHRNA7 (0.42) | DRD2DRD3KDM4EMAPTGAA | |
| SCHEMBL3584990 | 0.79 | ALDH1A1 (0.47) | DRD2DRD3ADRA2CKDM4EMAPT | |
| SCHEMBL3589113 | 0.79 | DRD2 (0.50) | DRD2DRD3DRD4HTR2AADRA2C | |
| SCHEMBL3595550 | 0.77 | DRD2 (0.55) | DRD2DRD3DRD4HTR2AADRA2C | |
| SCHEMBL3584991 | 0.77 | ALDH1A1 (0.41) | DRD2DRD3ADRA2CKDM4EMAPT | |
| SCHEMBL188362 | 0.76 | ADRA2C (0.42) | DRD2DRD3DRD4HTR2ADRD1 | |
| SCHEMBL4113163 | 0.76 | DRD2 (0.51) | DRD2DRD3DRD4HTR2AADRA2C | |
| SCHEMBL3582056 | 0.76 | ADRA2C (0.39) | DRD2DRD3DRD4HTR2ADRD1 | |
| SCHEMBL285241 | 0.76 | DRD2 (0.60) | DRD2DRD3DRD4HTR2AADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099167-A1 | Organic compounds | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH | 2009-04-16 | — | — | US | disclosed |
| US-20050222171-A1 | Organic compounds | NOVARTIS AG (CH) | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222171-A1 | Organic compounds | JAK1, MAP3K5, MAP3K7 | DRD2 4217/4885DRD3 4035/4885DRD4 4054/4885 |
| US-20090099167-A1 | Organic compounds | JAK1, MAP3K5, MAP3K7 | DRD2 4217/4885DRD3 4035/4885DRD4 4054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.